ARISTEIA CAPITAL, L.L.C. - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 25 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
ARISTEIA CAPITAL, L.L.C. ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$17,000
-50.0%
223,1350.0%0.00%
-100.0%
Q1 2022$34,000
-44.3%
223,1350.0%0.00%0.0%
Q4 2021$61,000
-79.0%
223,135
-45.2%
0.00%
-80.0%
Q3 2021$291,000–407,360–0.01%–
 Download
Other shareholders

There were no reported owners of CLARUS THERAPEUTICS HLDNGS I in Q3 2021.

NameSharesValueWeighting ↓
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders